Sulzberger-Garbe Syndrome: Difference between revisions
Jump to navigation
Jump to search
Created page with "_NOTOC__ {{Infobox Disease | Name = {{PAGENAME}} | Image = | Caption = | DiseasesDB = | ICD10 = L98.8 (ILDS L98.880) | ICD9 ..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Infobox Disease | {{Infobox Disease | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Line 14: | Line 14: | ||
| MeshID = | | MeshID = | ||
}} | }} | ||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
{{SK}} Oid-oid disease | |||
==Overview== | |||
'''Sulzberger–Garbe syndrome''' (also known as "Oid-oid disease"<ref name="Bolognia" />) is a cutaneous condition, a type of therapy resistant [[nummular eczema]].<ref name="Bolognia">{{cite book |author=Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. |title=Dermatology: 2-Volume Set |publisher=Mosby |location=St. Louis |year=2007 |pages= |isbn=1-4160-2999-0 |oclc= |doi= |accessdate=}}</ref> | '''Sulzberger–Garbe syndrome''' (also known as "Oid-oid disease"<ref name="Bolognia" />) is a cutaneous condition, a type of therapy resistant [[nummular eczema]].<ref name="Bolognia">{{cite book |author=Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. |title=Dermatology: 2-Volume Set |publisher=Mosby |location=St. Louis |year=2007 |pages= |isbn=1-4160-2999-0 |oclc= |doi= |accessdate=}}</ref> | ||
==References== | |||
{{Reflist|2}} | |||
== See also == | == See also == | ||
* [[ | * [[Eczema]] | ||
* [[ | * [[Papulosquamous lesions]] | ||
[[Category: | [[Category:Dermatology]] | ||
Revision as of 04:00, 29 July 2013
| Sulzberger-Garbe Syndrome | |
| ICD-10 | L98.8 (ILDS L98.880) |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Oid-oid disease
Overview
Sulzberger–Garbe syndrome (also known as "Oid-oid disease"[1]) is a cutaneous condition, a type of therapy resistant nummular eczema.[1]
References
- ↑ 1.0 1.1 Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.